Shaps H J, Snyder G E, Sama A E, Rudolph G S
Department of Emergency Medicine, North Shore University Hospital, Manhasset, NY 11030, USA.
Ann Emerg Med. 2001 Oct;38(4):447-9. doi: 10.1067/mem.2001.116615.
Hemorrhagic complications of tissue plasminogen activator (tPA) are well known. We report a case of a lingual hematoma that developed after tPA administration for an acute ischemic stroke that necessitated orotracheal intubation to maintain the patient's airway. This case demonstrates the need for thorough preadministration physical examination, as well as careful monitoring during infusion and after administration of this potent therapeutic agent.
组织型纤溶酶原激活剂(tPA)的出血并发症是众所周知的。我们报告一例在使用tPA治疗急性缺血性卒中后发生舌部血肿的病例,该病例需要进行气管插管以维持患者气道。此病例表明,在使用这种强效治疗药物之前需要进行全面的体格检查,以及在输注期间和给药后进行仔细监测。